OPEN END TURBO LONG - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME992B7

Market Closed - Bid/Ask 03:42:44 2024-06-04 pm EDT Pre-market 02:09:57 am
8.8 EUR +0.34% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO. 8.895 +1.08%
Current month+8.11%
1 month+0.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-04 8.8 +0.34%
24-06-03 8.77 +7.74%
24-05-31 8.14 +5.17%
24-05-30 7.74 +0.65%
24-05-29 7.69 -0.52%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 03:42 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME992B
ISINDE000ME992B7
Date issued 2024-02-26
Strike 143.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 9.65
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.92
Lowest since issue 7.5

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.85%
Consensus